HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner registers 'strong concerns' over suppression of science films

WASHINGTON, D.C.-The following letter was sent Monday 28 March 2005 to 410 members of the Association of Science-Technology Centers by Alan I Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science. The letter was prompted by recent reports that Imax theaters in at least a dozen U.S. cities have declined to show films that endorse the science of evolution.

Dear Colleagues:

The American Association for the Advancement of Science (AAAS), the world's largest general scientific society, shares with science and technology centers and museums a deep commitment to improved public understanding of science and the role it plays in people's lives. We are writing now to express strong concerns about increasing threats to science that endanger our shared missions and to offer our support and partnership in dealing with them.

A March 19, 2005 New York Times article-"A New Test for Imax: The Bible vs. the Volcano," by Cornelia Dean-raised serious issues about the future of science and scientific freedom in America. The article, which detailed the growing trend of science museums declining to show Imax films that mention the process of evolution, explains that fear of protests has prompted some museum managers to scrub such offerings from play lists. The films include "Galapagos," about the islands where Darwin theorized about evolution; and "Volcanoes of the Deep Sea," a look at life in the super-heated world of deep-sea vents.

The desire not to antagonize audiences and to avoid negative business outcomes is entirely understandable. Yet, the suppression of scientifically accurate information as a response to those with differing perspectives is inappropriate and threatens both the integrity of science and the broader public education to which we all are committed. It is also objectionable to many stakeholders-including many with strong religious c
'"/>


29-Mar-2005


Page: 1 2

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
4. AAAS CEO Alan I. Leshner statement on the UN cloning debate
5. New AAAS report cites serious concerns with electronic voting
6. Natural mechanism for immune suppression paves way for cancer trials
7. Oxidative stress stimulates p38 MAPK-mediated tumor suppression
8. Scripps Research study reveals new function of protein kinase pathway in tumor suppression
9. Transplant cures rats type 2 diabetes without need for immune suppression drugs
10. UCSF study shows suppression of telomerase enzyme can inhibit spread of melanoma
11. Wildfire suppression costs may be reduced using new model

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2018)... (PRWEB) , ... August 29, ... ... study validates first non-invasive technology to identify specific chromosomal abnormalities using morphological ... Ovation Fertility and Australia-based Life Whisperer suggests that ...
(Date:8/23/2018)... , ... August 21, 2018 , ... ... genomes of diverse cell types and species for the robust functional interrogation of ... for the development of T-cell based immunotherapies, the study of the autoimmunity, the ...
(Date:8/21/2018)... , ... August 21, 2018 , ... ... screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers a successful experience. ... visitors will find a seamless transition between products, with relevant details such as ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... September 11, 2018 , ... Sterlitech ... sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) to their ... H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic nature of ...
(Date:9/7/2018)... ... September 06, 2018 , ... Flagship Biosciences’ ... been validated to be as effective as manual pathology. The study, “Validation of ... Muscle Biopsies,” was published in the Archives of Pathology & Laboratory Medicine on ...
(Date:8/29/2018)... ... August 28, 2018 , ... Nanovis , ... the successful completion of a $5.5 million funding round managed by Commenda Securities. ... Commenda Capital, and Ellipsis Ventures. , “Our investment in Nanovis is consistent with ...
(Date:8/29/2018)... , ... August 28, 2018 , ... USDM Life ... the life sciences and healthcare industries, announces that Manu Vohra will deliver a presentation ... , What: “How to Implement Box for GxP in 30 Days” , When: ...
Breaking Biology Technology:
Cached News: